Sensing Platform– tag –
-
LMS and Impli Launch €6M International Challenge to Revolutionize Hormone Monitoring with BEAM Biosensor Platform for Simultaneous 5-Hormone Measurement
MRC Laboratory of Medical Sciences UK Overview MRC Laboratory of Medical Sciences (LMS) has partnered with technology company Impli in a €6 million international challenge to transform hormone monitoring. The program aims to extend Impli... -
CED Clinic Reviews Emerging Cannabinoid Biosensor Technology for Pain Management, Highlights Clinical Gaps
CED Clinic Unknown Overview A review published in the Journal of Pharmaceutical and Biomedical Analysis (2026), highlighted by CED Clinic, investigates emerging cannabinoid biosensor technology for pain management. The review explores tr... -
Electrochemical Hemoglobin Biosensor Achieves Ultrasensitive POCT Diagnosis with 0.09 pM Detection Limit
MDPI (Biosensors Journal) International Overview Research in MDPI's Biosensors Journal reports that electrochemical hemoglobin biosensors leverage enzymatic and affinity-based biosensing to achieve molecular specificity for POCT diagnost... -
FDA Approves Non-Invasive Biomarker Imaging Technology for Early Cardiovascular Disease Detection with 98.4% Sensitivity via Retinal Scan
news-today.us USA Overview The FDA has approved a groundbreaking non-invasive biomarker imaging technology capable of detecting subtle vascular inflammation during routine health check-ups. This optical biosensor platform achieves 98.4% ... -
bioRxiv Preprint: SMART-NeuroDx Unveils Reagent-Free, Machine-Learning Biosensor Platform for Point-of-Care Dementia Screening
bioRxiv International Overview A preprint on bioRxiv introduces SMART-NeuroDx, a reagent-free, multianalyte biosensor platform featuring a machine-learning readout for point-of-care dementia screening. The platform utilizes a four-channe... -
Trinity Biotech and Latch Medical Partner to Develop Precision Therapies for Metabolic Conditions Using Real-Time Biosensor Data
BioWorld International Overview Trinity Biotech plc has partnered with Latch Medical Ltd. to integrate data from Trinity's CGM+ wearable biosensor platform with Latch Medical's drug delivery technologies. The collaboration aims to develo... -
Trinity Biotech and Latch Medical Forge Alliance for AI-Powered Precision Intradermal Drug Delivery in Metabolic Disorders
GlobeNewswire (via Trinity Biotech plc) Ireland Overview Trinity Biotech has announced a strategic partnership with Latch Medical, integrating Trinity's AI-native CGM+ wearable biosensor platform with Latch Medical's innovative intraderm... -
bioRxiv: SMART-NeuroDx Achieves Reagent-Free, ML-Driven 4-Analyte Dementia Screening with LoD of 0.087 pg/mL
bioRxiv USA Overview A preprint published on bioRxiv on July 23, 2026, describes SMART-NeuroDx, a reagent-free multianalyte biosensor platform with machine-learning (ML) readout. Aimed at point-of-care dementia screening, this platform a... -
AI-Native Biosensors Fuel Precision Drug Delivery: Trinity Biotech and Latch Medical Target Diabetes, Obesity
GlobeNewswire (Trinity Biotech) Ireland Overview Trinity Biotech and Latch Medical have formed a strategic partnership to revolutionize diabetes and obesity treatment. The collaboration integrates Trinity Biotech's AI-native CGM+ wearabl... -
Iowa State University Develops Graphene Biosensor for Real-time Sub-ppb Pesticide Detection
HALO Science (Iowa State University) USA Overview Researchers at Iowa State University have developed a low-cost, field-deployable graphene-based microfluidic biosensor platform for rapid quantification of pesticide drift and runoff in a...
12